Active substance:
- Myxoma virus, strain 009, expressing capsid protein gene of Rabbit haemorrhagic disease virus, Live
- Myxoma virus, strain MK1899, expressing capsid protein gene of Rabbit haemorrhagic disease virus 2, Live
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Target species:
-
Rabbit